Iron Mountain Inc. (0JDP)
London Exchange · UK · prices in USD · close of 21 Oct 2026
Key indicators
| Last close | USD 115.39 |
|---|---|
| 52-week range | 76.20 – 134.26 |
| Return, 1 month / 3 months | −2.1% / −6.5% |
| Return, 1 year / 3 years | +16.7% / +112.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 53 |
| Volatility (1 year) | 33.6% |
| Worst drawdown (1 year) | -25.9% |
| Average daily value traded | 0.04M USD |
| Dividend yield | 3.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Iron Mountain is a records management company based in Boston, Massachusetts. It stores physical documents, tapes and other media for businesses, governments and other organisations, and provides related services such as secure shredding, data backup and information management. Its customers include companies of many sizes that need to keep records safe and accessible, and it also offers digital storage and data centre services alongside its traditional paper archive business.
The shares are listed on the London Exchange in UK under the code 0JDP, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Iron Mountain Inc. (0JDP) trades on the London Exchange in UK. It last closed at USD 115.39 on 21 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 1,987 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.7% and over the last three months it fell 6.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.5% | ||
| From 52-week high | -12.4% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.5% | ||
| 6-month return | -2.5% | ||
| 12-month return, skipping the last month | 19.2% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.9% | ||
| Liquidity | 22 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.04M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 78 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.0% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.0% |
|---|---|
| 1 month | −2.1% |
| 3 months | −6.5% |
| 6 months | −2.5% |
| 1 year | +16.7% |
| 3 years | +112.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 116.14 / 112.57 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.98 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Sep 2026 | USD 0.8640 |
| 12 Jun 2026 | USD 0.8640 |
| 13 Mar 2026 | USD 0.8640 |
| 12 Dec 2025 | USD 0.8640 |
| 15 Sep 2025 | USD 0.7850 |
| 16 Jun 2025 | USD 0.7850 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.